Global Metabotropic Glutamate Receptor 3 Market Growth (Status and Outlook) 2025-2031

October 2025 | 99 pages | ID: G7C3CF2C66E4EN
LP Information

Abstracts

According to this study, the global Metabotropic Glutamate Receptor 3 market size will reach US$ million by 2031.

United States market for Metabotropic Glutamate Receptor 3 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Metabotropic Glutamate Receptor 3 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Metabotropic Glutamate Receptor 3 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Metabotropic Glutamate Receptor 3 players cover Addex Therapeutics Ltd, Aevi Genomic Medicine Inc, Denovo Biopharma LLC, Domain Therapeutics SA, Eli Lilly and Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the ?Metabotropic Glutamate Receptor 3 Industry Forecast? looks at past sales and reviews total world Metabotropic Glutamate Receptor 3 sales in 2024, providing a comprehensive analysis by region and market sector of projected Metabotropic Glutamate Receptor 3 sales for 2025 through 2031. With Metabotropic Glutamate Receptor 3 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Metabotropic Glutamate Receptor 3 industry.

This Insight Report provides a comprehensive analysis of the global Metabotropic Glutamate Receptor 3 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Metabotropic Glutamate Receptor 3 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Metabotropic Glutamate Receptor 3 market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Metabotropic Glutamate Receptor 3 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Metabotropic Glutamate Receptor 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Metabotropic Glutamate Receptor 3 market by product type, application, key players and key regions and countries.

Segmentation by Type:

• LY-3020371
• VU-0092273
• DT-010991
• Others

Segmentation by Application:

• Autism
• Chronic Pain
• Glioma
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Addex Therapeutics Ltd
• Aevi Genomic Medicine Inc
• Denovo Biopharma LLC
• Domain Therapeutics SA
• Eli Lilly and Company
• Prexton Therapeutics SA

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Metabotropic Glutamate Receptor 3 Market Size (2020-2031)
  2.1.2 Metabotropic Glutamate Receptor 3 Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Metabotropic Glutamate Receptor 3 by Country/Region (2020, 2024 & 2031)
2.2 Metabotropic Glutamate Receptor 3 Segment by Type
  2.2.1 LY-3020371
  2.2.2 VU-0092273
  2.2.3 DT-010991
  2.2.4 Others
2.3 Metabotropic Glutamate Receptor 3 Market Size by Type
  2.3.1 Metabotropic Glutamate Receptor 3 Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Metabotropic Glutamate Receptor 3 Market Size Market Share by Type (2020-2025)
2.4 Metabotropic Glutamate Receptor 3 Segment by Application
  2.4.1 Autism
  2.4.2 Chronic Pain
  2.4.3 Glioma
  2.4.4 Others
2.5 Metabotropic Glutamate Receptor 3 Market Size by Application
  2.5.1 Metabotropic Glutamate Receptor 3 Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Metabotropic Glutamate Receptor 3 Market Size Market Share by Application (2020-2025)

3 METABOTROPIC GLUTAMATE RECEPTOR 3 MARKET SIZE BY PLAYER

3.1 Metabotropic Glutamate Receptor 3 Market Size Market Share by Player
  3.1.1 Global Metabotropic Glutamate Receptor 3 Revenue by Player (2020-2025)
  3.1.2 Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Player (2020-2025)
3.2 Global Metabotropic Glutamate Receptor 3 Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 METABOTROPIC GLUTAMATE RECEPTOR 3 BY REGION

4.1 Metabotropic Glutamate Receptor 3 Market Size by Region (2020-2025)
4.2 Global Metabotropic Glutamate Receptor 3 Annual Revenue by Country/Region (2020-2025)
4.3 Americas Metabotropic Glutamate Receptor 3 Market Size Growth (2020-2025)
4.4 APAC Metabotropic Glutamate Receptor 3 Market Size Growth (2020-2025)
4.5 Europe Metabotropic Glutamate Receptor 3 Market Size Growth (2020-2025)
4.6 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Metabotropic Glutamate Receptor 3 Market Size by Country (2020-2025)
5.2 Americas Metabotropic Glutamate Receptor 3 Market Size by Type (2020-2025)
5.3 Americas Metabotropic Glutamate Receptor 3 Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Metabotropic Glutamate Receptor 3 Market Size by Region (2020-2025)
6.2 APAC Metabotropic Glutamate Receptor 3 Market Size by Type (2020-2025)
6.3 APAC Metabotropic Glutamate Receptor 3 Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Metabotropic Glutamate Receptor 3 Market Size by Country (2020-2025)
7.2 Europe Metabotropic Glutamate Receptor 3 Market Size by Type (2020-2025)
7.3 Europe Metabotropic Glutamate Receptor 3 Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Metabotropic Glutamate Receptor 3 by Region (2020-2025)
8.2 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Type (2020-2025)
8.3 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL METABOTROPIC GLUTAMATE RECEPTOR 3 MARKET FORECAST

10.1 Global Metabotropic Glutamate Receptor 3 Forecast by Region (2026-2031)
  10.1.1 Global Metabotropic Glutamate Receptor 3 Forecast by Region (2026-2031)
  10.1.2 Americas Metabotropic Glutamate Receptor 3 Forecast
  10.1.3 APAC Metabotropic Glutamate Receptor 3 Forecast
  10.1.4 Europe Metabotropic Glutamate Receptor 3 Forecast
  10.1.5 Middle East & Africa Metabotropic Glutamate Receptor 3 Forecast
10.2 Americas Metabotropic Glutamate Receptor 3 Forecast by Country (2026-2031)
  10.2.1 United States Market Metabotropic Glutamate Receptor 3 Forecast
  10.2.2 Canada Market Metabotropic Glutamate Receptor 3 Forecast
  10.2.3 Mexico Market Metabotropic Glutamate Receptor 3 Forecast
  10.2.4 Brazil Market Metabotropic Glutamate Receptor 3 Forecast
10.3 APAC Metabotropic Glutamate Receptor 3 Forecast by Region (2026-2031)
  10.3.1 China Metabotropic Glutamate Receptor 3 Market Forecast
  10.3.2 Japan Market Metabotropic Glutamate Receptor 3 Forecast
  10.3.3 Korea Market Metabotropic Glutamate Receptor 3 Forecast
  10.3.4 Southeast Asia Market Metabotropic Glutamate Receptor 3 Forecast
  10.3.5 India Market Metabotropic Glutamate Receptor 3 Forecast
  10.3.6 Australia Market Metabotropic Glutamate Receptor 3 Forecast
10.4 Europe Metabotropic Glutamate Receptor 3 Forecast by Country (2026-2031)
  10.4.1 Germany Market Metabotropic Glutamate Receptor 3 Forecast
  10.4.2 France Market Metabotropic Glutamate Receptor 3 Forecast
  10.4.3 UK Market Metabotropic Glutamate Receptor 3 Forecast
  10.4.4 Italy Market Metabotropic Glutamate Receptor 3 Forecast
  10.4.5 Russia Market Metabotropic Glutamate Receptor 3 Forecast
10.5 Middle East & Africa Metabotropic Glutamate Receptor 3 Forecast by Region (2026-2031)
  10.5.1 Egypt Market Metabotropic Glutamate Receptor 3 Forecast
  10.5.2 South Africa Market Metabotropic Glutamate Receptor 3 Forecast
  10.5.3 Israel Market Metabotropic Glutamate Receptor 3 Forecast
  10.5.4 Turkey Market Metabotropic Glutamate Receptor 3 Forecast
10.6 Global Metabotropic Glutamate Receptor 3 Forecast by Type (2026-2031)
10.7 Global Metabotropic Glutamate Receptor 3 Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Metabotropic Glutamate Receptor 3 Forecast

11 KEY PLAYERS ANALYSIS

11.1 Addex Therapeutics Ltd
  11.1.1 Addex Therapeutics Ltd Company Information
  11.1.2 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Product Offered
  11.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Addex Therapeutics Ltd Main Business Overview
  11.1.5 Addex Therapeutics Ltd Latest Developments
11.2 Aevi Genomic Medicine Inc
  11.2.1 Aevi Genomic Medicine Inc Company Information
  11.2.2 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Product Offered
  11.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Aevi Genomic Medicine Inc Main Business Overview
  11.2.5 Aevi Genomic Medicine Inc Latest Developments
11.3 Denovo Biopharma LLC
  11.3.1 Denovo Biopharma LLC Company Information
  11.3.2 Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Product Offered
  11.3.3 Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Denovo Biopharma LLC Main Business Overview
  11.3.5 Denovo Biopharma LLC Latest Developments
11.4 Domain Therapeutics SA
  11.4.1 Domain Therapeutics SA Company Information
  11.4.2 Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Product Offered
  11.4.3 Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Domain Therapeutics SA Main Business Overview
  11.4.5 Domain Therapeutics SA Latest Developments
11.5 Eli Lilly and Company
  11.5.1 Eli Lilly and Company Company Information
  11.5.2 Eli Lilly and Company Metabotropic Glutamate Receptor 3 Product Offered
  11.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 3 Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Eli Lilly and Company Main Business Overview
  11.5.5 Eli Lilly and Company Latest Developments
11.6 Prexton Therapeutics SA
  11.6.1 Prexton Therapeutics SA Company Information
  11.6.2 Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Product Offered
  11.6.3 Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Prexton Therapeutics SA Main Business Overview
  11.6.5 Prexton Therapeutics SA Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Metabotropic Glutamate Receptor 3 Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Metabotropic Glutamate Receptor 3 Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of LY-3020371
Table 4. Major Players of VU-0092273
Table 5. Major Players of DT-010991
Table 6. Major Players of Others
Table 7. Metabotropic Glutamate Receptor 3 Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Metabotropic Glutamate Receptor 3 Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Metabotropic Glutamate Receptor 3 Market Size Market Share by Type (2020-2025)
Table 10. Metabotropic Glutamate Receptor 3 Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Metabotropic Glutamate Receptor 3 Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Metabotropic Glutamate Receptor 3 Market Size Market Share by Application (2020-2025)
Table 13. Global Metabotropic Glutamate Receptor 3 Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Player (2020-2025)
Table 15. Metabotropic Glutamate Receptor 3 Key Players Head office and Products Offered
Table 16. Metabotropic Glutamate Receptor 3 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Metabotropic Glutamate Receptor 3 Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Metabotropic Glutamate Receptor 3 Market Size Market Share by Region (2020-2025)
Table 21. Global Metabotropic Glutamate Receptor 3 Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Metabotropic Glutamate Receptor 3 Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Metabotropic Glutamate Receptor 3 Market Size Market Share by Country (2020-2025)
Table 25. Americas Metabotropic Glutamate Receptor 3 Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Metabotropic Glutamate Receptor 3 Market Size Market Share by Type (2020-2025)
Table 27. Americas Metabotropic Glutamate Receptor 3 Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Metabotropic Glutamate Receptor 3 Market Size Market Share by Application (2020-2025)
Table 29. APAC Metabotropic Glutamate Receptor 3 Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Metabotropic Glutamate Receptor 3 Market Size Market Share by Region (2020-2025)
Table 31. APAC Metabotropic Glutamate Receptor 3 Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Metabotropic Glutamate Receptor 3 Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Metabotropic Glutamate Receptor 3 Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Metabotropic Glutamate Receptor 3 Market Size Market Share by Country (2020-2025)
Table 35. Europe Metabotropic Glutamate Receptor 3 Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Metabotropic Glutamate Receptor 3 Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Metabotropic Glutamate Receptor 3
Table 41. Key Market Challenges & Risks of Metabotropic Glutamate Receptor 3
Table 42. Key Industry Trends of Metabotropic Glutamate Receptor 3
Table 43. Global Metabotropic Glutamate Receptor 3 Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Metabotropic Glutamate Receptor 3 Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Metabotropic Glutamate Receptor 3 Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Metabotropic Glutamate Receptor 3 Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Addex Therapeutics Ltd Details, Company Type, Metabotropic Glutamate Receptor 3 Area Served and Its Competitors
Table 48. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Product Offered
Table 49. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Addex Therapeutics Ltd Main Business
Table 51. Addex Therapeutics Ltd Latest Developments
Table 52. Aevi Genomic Medicine Inc Details, Company Type, Metabotropic Glutamate Receptor 3 Area Served and Its Competitors
Table 53. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Product Offered
Table 54. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Aevi Genomic Medicine Inc Main Business
Table 56. Aevi Genomic Medicine Inc Latest Developments
Table 57. Denovo Biopharma LLC Details, Company Type, Metabotropic Glutamate Receptor 3 Area Served and Its Competitors
Table 58. Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Product Offered
Table 59. Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Denovo Biopharma LLC Main Business
Table 61. Denovo Biopharma LLC Latest Developments
Table 62. Domain Therapeutics SA Details, Company Type, Metabotropic Glutamate Receptor 3 Area Served and Its Competitors
Table 63. Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Product Offered
Table 64. Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Domain Therapeutics SA Main Business
Table 66. Domain Therapeutics SA Latest Developments
Table 67. Eli Lilly and Company Details, Company Type, Metabotropic Glutamate Receptor 3 Area Served and Its Competitors
Table 68. Eli Lilly and Company Metabotropic Glutamate Receptor 3 Product Offered
Table 69. Eli Lilly and Company Metabotropic Glutamate Receptor 3 Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Eli Lilly and Company Main Business
Table 71. Eli Lilly and Company Latest Developments
Table 72. Prexton Therapeutics SA Details, Company Type, Metabotropic Glutamate Receptor 3 Area Served and Its Competitors
Table 73. Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Product Offered
Table 74. Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Prexton Therapeutics SA Main Business
Table 76. Prexton Therapeutics SA Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Metabotropic Glutamate Receptor 3 Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Metabotropic Glutamate Receptor 3 Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Metabotropic Glutamate Receptor 3 Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Metabotropic Glutamate Receptor 3 Sales Market Share by Country/Region (2024)
Figure 8. Metabotropic Glutamate Receptor 3 Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Metabotropic Glutamate Receptor 3 Market Size Market Share by Type in 2024
Figure 10. Metabotropic Glutamate Receptor 3 in Autism
Figure 11. Global Metabotropic Glutamate Receptor 3 Market: Autism (2020-2025) & ($ millions)
Figure 12. Metabotropic Glutamate Receptor 3 in Chronic Pain
Figure 13. Global Metabotropic Glutamate Receptor 3 Market: Chronic Pain (2020-2025) & ($ millions)
Figure 14. Metabotropic Glutamate Receptor 3 in Glioma
Figure 15. Global Metabotropic Glutamate Receptor 3 Market: Glioma (2020-2025) & ($ millions)
Figure 16. Metabotropic Glutamate Receptor 3 in Others
Figure 17. Global Metabotropic Glutamate Receptor 3 Market: Others (2020-2025) & ($ millions)
Figure 18. Global Metabotropic Glutamate Receptor 3 Market Size Market Share by Application in 2024
Figure 19. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Player in 2024
Figure 20. Global Metabotropic Glutamate Receptor 3 Market Size Market Share by Region (2020-2025)
Figure 21. Americas Metabotropic Glutamate Receptor 3 Market Size 2020-2025 ($ millions)
Figure 22. APAC Metabotropic Glutamate Receptor 3 Market Size 2020-2025 ($ millions)
Figure 23. Europe Metabotropic Glutamate Receptor 3 Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size 2020-2025 ($ millions)
Figure 25. Americas Metabotropic Glutamate Receptor 3 Value Market Share by Country in 2024
Figure 26. United States Metabotropic Glutamate Receptor 3 Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Metabotropic Glutamate Receptor 3 Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Metabotropic Glutamate Receptor 3 Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Metabotropic Glutamate Receptor 3 Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Metabotropic Glutamate Receptor 3 Market Size Market Share by Region in 2024
Figure 31. APAC Metabotropic Glutamate Receptor 3 Market Size Market Share by Type (2020-2025)
Figure 32. APAC Metabotropic Glutamate Receptor 3 Market Size Market Share by Application (2020-2025)
Figure 33. China Metabotropic Glutamate Receptor 3 Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Metabotropic Glutamate Receptor 3 Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Metabotropic Glutamate Receptor 3 Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Metabotropic Glutamate Receptor 3 Market Size Growth 2020-2025 ($ millions)
Figure 37. India Metabotropic Glutamate Receptor 3 Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Metabotropic Glutamate Receptor 3 Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Metabotropic Glutamate Receptor 3 Market Size Market Share by Country in 2024
Figure 40. Europe Metabotropic Glutamate Receptor 3 Market Size Market Share by Type (2020-2025)
Figure 41. Europe Metabotropic Glutamate Receptor 3 Market Size Market Share by Application (2020-2025)
Figure 42. Germany Metabotropic Glutamate Receptor 3 Market Size Growth 2020-2025 ($ millions)
Figure 43. France Metabotropic Glutamate Receptor 3 Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Metabotropic Glutamate Receptor 3 Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Metabotropic Glutamate Receptor 3 Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Metabotropic Glutamate Receptor 3 Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Metabotropic Glutamate Receptor 3 Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Metabotropic Glutamate Receptor 3 Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Metabotropic Glutamate Receptor 3 Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Metabotropic Glutamate Receptor 3 Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Metabotropic Glutamate Receptor 3 Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 56. APAC Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 57. Europe Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 59. United States Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 60. Canada Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 61. Mexico Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 62. Brazil Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 63. China Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 64. Japan Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 65. Korea Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 67. India Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 68. Australia Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 69. Germany Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 70. France Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 71. UK Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 72. Italy Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 73. Russia Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 74. Egypt Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 75. South Africa Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 76. Israel Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 77. Turkey Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)
Figure 78. Global Metabotropic Glutamate Receptor 3 Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Metabotropic Glutamate Receptor 3 Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Metabotropic Glutamate Receptor 3 Market Size 2026-2031 ($ millions)